Publicacions en què col·labora amb Rafael Esteban (7)

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

2017

  1. Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

    Journal of Viral Hepatitis, Vol. 24, Núm. 4, pp. 304-311

2016

  1. Erratum: High-resolution hepatitis c virus subtyping using ns5b deep sequencing and phylogeny, an alternative to current methods (Journal of Clinical Microbiology (2015) 53:1 (219-226))

    Journal of Clinical Microbiology

2015

  1. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

    Journal of Clinical Microbiology, Vol. 53, Núm. 1, pp. 219-226

  2. Perfil clínico y seguimiento de los pacientes con hepatitis C crónica en hospitales españoles: Estudio disHCovery

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 145-153

2006

  1. Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

    Alimentary Pharmacology and Therapeutics, Vol. 23, Núm. 3, pp. 409-419

1991

  1. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites

    New England Journal of Medicine, Vol. 325, Núm. 12, pp. 829-835